Numerous molecular targeting agents have been created as a result of the discovery of genetic abnormalities and the investigation of various cellular signalling pathways. These agents can be used as therapeutic targets for a variety of diseases. Many new medications have been become available recently to treat breast cancer. These medications can be used orally or intravenously. These drug delivery techniques reduce toxicity and boost effectiveness. The patients have benefited in numerous ways from these new medications and delivery systems, which have replaced the more time-consuming older ones. They have fewer adverse effects and provide patients with better benefits.
Author (s) Details
Nadeem Kizilbash
Department of Chemistry, Faculty of
Physical Sciences, Quaid-i-Azam University, Islamabad-45320, Pakistan.
Marjan Assefi
University of North Carolina at Greensboro,
Greensboro, NC 27403, USA.
Naila Mahmood
Molecular Immunology Laboratory,
Atta-ur-Rehman School of Applied Biosciences, National University of Science
and Technology, Islamabad, Pakistan.
Sohila Nankali
Northcentral University, San Diego, CA,
USA.
A. Nanklai
Kermanshah University of Medical Sciences,
Kermanshah, Iran.
Gholamreza Abdi
Department of Biotechnology, Persian Gulf
Research Institute, Bushehr, 75169, Iran.
View Book :- https://stm.bookpi.org/CPMS-V6/article/view/7686
No comments:
Post a Comment